InterventionsHuman trial12 weeksRandomised trialDouble-blindPlacebo-controlledRegistered ChiCTR2600116148
Safety, Pharmacokinetics and Pharmacodynamics of the GLP-1/GIP/GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo-Controlled Phase 1a/1b Study
Diabetes, Obesity & Metabolism
The paper
Guoping Yang, Ya‐xin Liu, Jinlian Xie, Ping Jin
Show 11 more authors
Shan Zeng, Jing Xiong, Ling Wei, Hai‐yan Zhang, Tao Su, Yu-xiu Xu, Liang Huang, Thomas Holst‐Hansen, Sofie Bay, Hui‐ru Yan, Jie Huang,Central South University · Third Xiangya Hospital
Diabetes, Obesity & Metabolism · 8 Sep 2026